Bharati R Dhruva

Array ( [id] => 5580484 [patent_doc_number] => 20090175830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'ONCOLYTIC ADENOVIRUS ARMED WITH THERAPEUTIC GENES' [patent_app_type] => utility [patent_app_number] => 12/370232 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 71473 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175830.pdf [firstpage_image] =>[orig_patent_app_number] => 12370232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514186 [patent_doc_number] => 20090214492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'ISOLATED STROMAL CELLS FOR USE IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/356427 [patent_app_country] => US [patent_app_date] => 2009-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19506 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214492.pdf [firstpage_image] =>[orig_patent_app_number] => 12356427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379753 [patent_doc_number] => 20090191592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'GLYCOENGINEERED, RECOMBINANT ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/351635 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 77464 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191592.pdf [firstpage_image] =>[orig_patent_app_number] => 12351635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379360 [patent_doc_number] => 20090191199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'GLYCOENGINEERED, RECOMBINANT ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/351695 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 77461 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191199.pdf [firstpage_image] =>[orig_patent_app_number] => 12351695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6235303 [patent_doc_number] => 20100267007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'SOLID-FLUID COMPOSITION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/350710 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 25154 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267007.pdf [firstpage_image] =>[orig_patent_app_number] => 12350710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038375 [patent_doc_number] => 20110091424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'ORAL DOSAGE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/937725 [patent_app_country] => US [patent_app_date] => 2009-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5973 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091424.pdf [firstpage_image] =>[orig_patent_app_number] => 12937725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9468987 [patent_doc_number] => 08722617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'Mussel adhesive protein derived vectors for gene delivery' [patent_app_type] => utility [patent_app_number] => 12/344773 [patent_app_country] => US [patent_app_date] => 2008-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4094 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12344773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5461067 [patent_doc_number] => 20090321267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'METHOD FOR SURFACE TREATING PLASTIC PRODUCTS' [patent_app_type] => utility [patent_app_number] => 12/333435 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 745 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0321/20090321267.pdf [firstpage_image] =>[orig_patent_app_number] => 12333435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479543 [patent_doc_number] => 20100041739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Transfection Reagent' [patent_app_type] => utility [patent_app_number] => 12/333453 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7590 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041739.pdf [firstpage_image] =>[orig_patent_app_number] => 12333453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066247 [patent_doc_number] => 20110243897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS' [patent_app_type] => utility [patent_app_number] => 13/139151 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11553 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243897.pdf [firstpage_image] =>[orig_patent_app_number] => 13139151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304269 [patent_doc_number] => 20090298921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'METHODS AND COMPOSITIONS FOR USE IN HOMOLOGOUS RECOMBINATION' [patent_app_type] => utility [patent_app_number] => 12/327740 [patent_app_country] => US [patent_app_date] => 2008-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12639 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298921.pdf [firstpage_image] =>[orig_patent_app_number] => 12327740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10154565 [patent_doc_number] => 09186317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Active nanoparticles and method of using' [patent_app_type] => utility [patent_app_number] => 12/313847 [patent_app_country] => US [patent_app_date] => 2008-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 28 [patent_no_of_words] => 13433 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12313847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650846 [patent_doc_number] => 20110300115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'USE OF INDUCTOR AGENTS GSE24.2 FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING ILLNESSES RELATING TO CELLULAR SENESCENCE' [patent_app_type] => utility [patent_app_number] => 12/743886 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11778 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300115.pdf [firstpage_image] =>[orig_patent_app_number] => 12743886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5584952 [patent_doc_number] => 20090104154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Composition and method for killing of tumours' [patent_app_type] => utility [patent_app_number] => 12/292499 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7878 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104154.pdf [firstpage_image] =>[orig_patent_app_number] => 12292499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9704045 [patent_doc_number] => 08829109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Cleavable modifications to reducible poly(amido ethylenimine)s to enhance nucleotide delivery' [patent_app_type] => utility [patent_app_number] => 12/266980 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 4793 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12266980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6503842 [patent_doc_number] => 20100260745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'METHODS OF USING AND CONSTRUCTING NANOSENSOR PLATFORMS' [patent_app_type] => utility [patent_app_number] => 12/680833 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13705 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260745.pdf [firstpage_image] =>[orig_patent_app_number] => 12680833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6309116 [patent_doc_number] => 20100069814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'SYSTEM AND METHOD FOR UTILIZING MICROBUBBLES AND LIPOSOMES AS VIRAL SEQUESTERING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/211748 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3744 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069814.pdf [firstpage_image] =>[orig_patent_app_number] => 12211748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422408 [patent_doc_number] => 20090148863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Nanoparticle biosensors' [patent_app_type] => utility [patent_app_number] => 12/232184 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21260 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148863.pdf [firstpage_image] =>[orig_patent_app_number] => 12232184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6269715 [patent_doc_number] => 20100298816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'MAGNETIC DELIVERY DEVICE' [patent_app_type] => utility [patent_app_number] => 12/677285 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12277 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298816.pdf [firstpage_image] =>[orig_patent_app_number] => 12677285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348899 [patent_doc_number] => 20090004260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'MEDICAMENT COMPRISING HGF GENE' [patent_app_type] => utility [patent_app_number] => 12/203661 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7456 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004260.pdf [firstpage_image] =>[orig_patent_app_number] => 12203661 [rel_patent_id] =>[rel_patent_doc_number] =>)